TY - JOUR
T1 - Professional perspectives towards implementing artificial intelligence in next generation sequencing–based newborn screening
T2 - A Q methodology study
AU - Soriano Longarón, Sara
AU - Johansson, Lennart
AU - Christiaans, Imke
AU - Birnie, Erwin
AU - van Gijn, Marielle
AU - Ranchor, Adelita V.
AU - Plantinga, Mirjam
N1 - Publisher Copyright:
© 2025 Fellowship of Postgraduate Medicine
PY - 2025/3
Y1 - 2025/3
N2 - Background: The use of next generation sequencing (NGS) to expand current newborn screening (NBS) is being explored. NGS would enable early detection of more early onset diseases. However, to interpret a large amount of data within a short turn-around time, it is necessary to use artificial intelligence (AI). Use of AI in NGS-based NBS raises ethical and societal issues that require investigation of how healthcare professionals view the use of AI in this context and which requirements need to be met to realize responsible development and deployment of AI in NGS-based NBS. Objective: To explore professionals’ perspectives on the requirements that are important for responsible development and deployment of AI in NGS-based NBS. Methods: Q methodology was used to examine the perspectives of professionals, involving two steps: 1) an online focus group discussion to provide input for the development of 40 statements regarding requirements for responsible use of AI in NGS-based NBS and 2) an online sorting by the participants (N = 30) of the list of statements, according to their importance. Results: The Q methodology approach identified two participant perspectives. The first emphasized the importance for professionals that they retain control over the task for which the AI is used. The second prioritized the importance of parental acceptance and of high uptake of the screening offer. Conclusions: The findings indicate an overall optimistic attitude and suggest that for responsible development and implementation of AI in an NGS-based NBS, it is important to consider requirements covering ethical, legal and societal aspects.
AB - Background: The use of next generation sequencing (NGS) to expand current newborn screening (NBS) is being explored. NGS would enable early detection of more early onset diseases. However, to interpret a large amount of data within a short turn-around time, it is necessary to use artificial intelligence (AI). Use of AI in NGS-based NBS raises ethical and societal issues that require investigation of how healthcare professionals view the use of AI in this context and which requirements need to be met to realize responsible development and deployment of AI in NGS-based NBS. Objective: To explore professionals’ perspectives on the requirements that are important for responsible development and deployment of AI in NGS-based NBS. Methods: Q methodology was used to examine the perspectives of professionals, involving two steps: 1) an online focus group discussion to provide input for the development of 40 statements regarding requirements for responsible use of AI in NGS-based NBS and 2) an online sorting by the participants (N = 30) of the list of statements, according to their importance. Results: The Q methodology approach identified two participant perspectives. The first emphasized the importance for professionals that they retain control over the task for which the AI is used. The second prioritized the importance of parental acceptance and of high uptake of the screening offer. Conclusions: The findings indicate an overall optimistic attitude and suggest that for responsible development and implementation of AI in an NGS-based NBS, it is important to consider requirements covering ethical, legal and societal aspects.
KW - Artificial intelligence
KW - Genetics
KW - Health professionals
KW - Healthcare innovation
KW - Machine learning
KW - Neonatal screening
KW - Next generation sequencing
KW - Q methodology
UR - http://www.scopus.com/inward/record.url?scp=85216760590&partnerID=8YFLogxK
U2 - 10.1016/j.hlpt.2025.100982
DO - 10.1016/j.hlpt.2025.100982
M3 - Article
AN - SCOPUS:85216760590
SN - 2211-8837
VL - 14
JO - Health policy and technology
JF - Health policy and technology
IS - 2
M1 - 100982
ER -